{{Rsnum
|rsid=3213545
|Gene=OASL
|Chromosome=12
|position=121033534
|Orientation=minus
|ReferenceAllele=C
|GMAF=0.314
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=OASL
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 45.5 | 48.2 | 6.2
| HCB | 25.4 | 55.2 | 19.4
| JPT | 18.8 | 48.2 | 33.0
| YRI | 82.3 | 16.3 | 1.4
| ASW | 73.7 | 24.6 | 1.8
| CHB | 25.4 | 55.2 | 19.4
| CHD | 33.0 | 45.9 | 21.1
| GIH | 32.0 | 48.0 | 20.0
| LWK | 70.0 | 28.2 | 1.8
| MEX | 45.6 | 45.6 | 8.8
| MKK | 76.9 | 21.2 | 1.9
| TSI | 46.1 | 44.1 | 9.8
| HapMapRevision=28
}}
{{PMID|18571276|OA=1
}} sustained virologic response significantly associated with 
*[[rs3213545]]: p=0.03, RR=1.27 (1.03-1.58) 
*[[rs1169279]]: p=0.02, RR=1.32 (1.05-1.65) 
*[[rs2859398]]: p=0.02, RR=1.29 (1.04-1.61)

{{PMID Auto GWAS
|PMID=21943158
|Trait=None
|Title=Genetic variants in LPL, OASL and TOMM40/APOE-C1-C2-C4 genes are associated with multiple cardiovascular-related traits.
|RiskAllele=A
|Pval=4E-15
|OR=0.1210
|ORtxt=[0.092-0.150] units/l decrease
|OA=1
}}

{{PMID Auto
|PMID=16235172
|Title=Single nucleotide polymorphisms in genes for 2'-5'-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection.
}}

{{PMID Auto
|PMID=19247438
|Title=Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man.
|OA=1
}}

{{PMID Auto
|PMID=24865988
|Title=Genetic variants associated with susceptibility of Ashkenazi Jews to West Nile virus infection
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}